367 related articles for article (PubMed ID: 26211517)
1. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
Gupta R; Yadav A; Misra R; Aggarwal A
Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
[TBL] [Abstract][Full Text] [Related]
2. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
Gupta R; Yadav A; Misra R; Aggarwal A
Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
[TBL] [Abstract][Full Text] [Related]
3. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
Gupta R; Aggarwal A; Sinha S; Rajasekhar L; Yadav A; Gaur P; Misra R; Negi VS
Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
[TBL] [Abstract][Full Text] [Related]
4. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
[TBL] [Abstract][Full Text] [Related]
5. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
[TBL] [Abstract][Full Text] [Related]
6. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
7. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.
Suzuki M; Wiers K; Brooks EB; Greis KD; Haines K; Klein-Gitelman MS; Olson J; Onel K; O'Neil KM; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
Pediatr Res; 2009 May; 65(5):530-6. PubMed ID: 19218887
[TBL] [Abstract][Full Text] [Related]
8. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
[TBL] [Abstract][Full Text] [Related]
9. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
11. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
12. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
13. Predictive role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
Elewa EA; El Tokhy MA; Fathy SE; Talaat AM
Lupus; 2015 Feb; 24(2):138-46. PubMed ID: 25199807
[TBL] [Abstract][Full Text] [Related]
14. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
Gupta R; Yadav A; Aggarwal A
Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649
[TBL] [Abstract][Full Text] [Related]
16. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
Davies JC; Carlsson E; Midgley A; Smith EMD; Bruce IN; Beresford MW; Hedrich CM;
Rheumatology (Oxford); 2021 Aug; 60(8):3747-3759. PubMed ID: 33313921
[TBL] [Abstract][Full Text] [Related]
17. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
Singh RG; Usha ; Rathore SS; Behura SK; Singh NK
Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858
[TBL] [Abstract][Full Text] [Related]
18. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous.
Loghman M; Haghighi A; Broumand B; Ataipour Y; Tohidi M; Marzbani C; Fakharran M
Int J Rheum Dis; 2016 Jul; 19(7):678-84. PubMed ID: 24467624
[TBL] [Abstract][Full Text] [Related]
19. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
20. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
